These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 4815845)
1. Donald E. Francke medal lecture: International aspects of drug use and abuse. Francke DE Am J Hosp Pharm; 1974 Feb; 31(2):130-6. PubMed ID: 4815845 [No Abstract] [Full Text] [Related]
2. Connecticut Prescription Monitoring and Reporting System (CPMRS). How prescribers and pharmacists can help reduce prescription drug misuse and abuse. Conn Med; 2008 Aug; 72(7):439-40. PubMed ID: 18763674 [No Abstract] [Full Text] [Related]
3. Drug dependence: an age-old problem compounded by old age. Pascarelli EF Geriatrics; 1974 Dec; 29(12):109-15. PubMed ID: 4426510 [No Abstract] [Full Text] [Related]
4. [Availability of psychotropic drugs and attitudes of the society towards behavioral disorders]. Pichot P Experientia Suppl; 1972; 17():286-303. PubMed ID: 4644543 [No Abstract] [Full Text] [Related]
5. International aspects of problems associated with the use of psychoactive drugs. Chruściel TL Bull Narc; 1976; 28(2):35-48. PubMed ID: 1048933 [TBL] [Abstract][Full Text] [Related]
6. [Psychopharmaca. Symposium at the National Convention of the Swedish Medical Society, Dec. 2, 1966, in Stockholm]. Holmberg G Nord Med; 1967 Dec; 78(50):1660. PubMed ID: 6073282 [No Abstract] [Full Text] [Related]
8. The impact of scientific models on clinical psychopharmacology: a pharmacologist's view. Lasagna L Semin Psychiatry; 1972 Aug; 4(3):271-82. PubMed ID: 4680225 [No Abstract] [Full Text] [Related]
9. [Unusual drugs used in the course of drug abuse]. Deniker P; Cottereau MJ; Colonna L; Lôo H Ann Med Psychol (Paris); 1971 Jul; 2(2):245-54. PubMed ID: 5123112 [No Abstract] [Full Text] [Related]
10. [Abuse of antiparkinsonian drugs among psychiatric patients]. Haggag A; Nissen T; Småbrekke A; Bratlid T Tidsskr Nor Laegeforen; 1986 Nov; 106(32):2734-6, 2753. PubMed ID: 3810596 [No Abstract] [Full Text] [Related]
11. [Significance, causes and prevention of drug-residues]. Taubert K Z Arztl Fortbild (Jena); 1976 Feb; 70(4):194-200. PubMed ID: 969650 [No Abstract] [Full Text] [Related]
12. [Prescription of drugs from medico-psychological points of view]. Langen D Munch Med Wochenschr; 1970 Dec; 112(49):2215-9. PubMed ID: 5536809 [No Abstract] [Full Text] [Related]
13. Legal problems in psychiatric drug prescription. Appleton WS Am J Psychiatry; 1968 Jan; 124(7):877-82. PubMed ID: 5688683 [No Abstract] [Full Text] [Related]
14. Drug dependence. Marjot DH J R Nav Med Serv; 1966; 52(3):150-6. PubMed ID: 5965904 [No Abstract] [Full Text] [Related]
15. Psychopharmacology. An historical perspective. Moriarty KM; Alagna SW; Lake CR Psychiatr Clin North Am; 1984 Sep; 7(3):411-33. PubMed ID: 6384957 [TBL] [Abstract][Full Text] [Related]
16. Drugs of the future and the future of drug distribution. Smith MC Am J Hosp Pharm; 1974 Jul; 31(7):677-83. PubMed ID: 4851453 [No Abstract] [Full Text] [Related]
17. The Bureau of Drug Abuse Control: a review of the first two years. Gunn JW J Forensic Sci; 1968 Jul; 13(3):302-17. PubMed ID: 5757498 [No Abstract] [Full Text] [Related]
18. Role of the pharmaceutical industry in preventing drug abuse. Skinner WJ Am J Pharm Sci Support Public Health; 1970; 142(4):184-8. PubMed ID: 5514567 [No Abstract] [Full Text] [Related]
19. Controlled prescription drug abuse at epidemic level. National Center on Addiction and Substance Abuse J Pain Palliat Care Pharmacother; 2006; 20(2):61-4. PubMed ID: 16702139 [TBL] [Abstract][Full Text] [Related]
20. History and current perspectives on the use of drug formulations to decrease the abuse of prescription drugs. Schuster CR Drug Alcohol Depend; 2006 Jun; 83 Suppl 1():S8-14. PubMed ID: 16483729 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]